| 106721-4 | Reason for discharge during assessment period | SURVEY.CMS |
| 106722-2 | Motor block intensity (qualitative) | CLIN |
| 106723-0 | Month of first prenatal care visit | OBGYN |
| 106724-8 | Pain level (qualitative) | CLIN |
| 106725-5 | Citizenship card Person Document | CLIN |
| 106726-3 | Myotonometry assessment (qualitative) | CLIN |
| 106727-1 | Adenovirus DNA (viral load) (naa with probe detection) | MICRO |
| 106728-9 | Alpha-hydroxy flualprazolam (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 106729-7 | Tissue perfusion and oxygenation (qualitative) | PULM |
| 10673-2 | Hepatitis B virus core Ag (Tissue, qualitative, immune stain) | MICRO |
| 106730-5 | Free from harm related to unintentional contamination of the sterile field and wound (qualitative) | SURVEY.PNDS |
| 106731-3 | Verbal memory count | CLIN |
| 106732-1 | Benzodiazepines panel - Serum, Plasma or Blood (confirmatory method) | PANEL.DRUG/TOX |
| 106733-9 | Troponin I.cardiac, Plasma or Blood (rapid immunoassay) | CHEM |
| 106734-7 | Troponin T.cardiac, Plasma or Blood (rapid immunoassay) | CHEM |
| 106735-4 | Natriuretic peptide.B prohormone N-Terminal, Plasma or Blood (rapid immunoassay) | CHEM |
| 106736-2 | C reactive protein, Plasma or Blood (rapid immunoassay) | CHEM |
| 106737-0 | Choriogonadotropin.intact+Beta subunit, Plasma or Blood (rapid immunoassay) | CHEM |
| 106738-8 | Brain weight/liver weight of Fetus | PATH |
| 106739-6 | Neurofascin-155 Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 10674-0 | Hepatitis B virus surface Ag (Tissue, qualitative, immune stain) | MICRO |
| 106740-4 | Neurofascin-140 Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 106741-2 | Neurofascin-186 Ab (qualitative, cell binding immunofluorescent assay) | SERO |
| 106742-0 | Letermovir (qualitative, genotype method) | ABXBACT |
| 106743-8 | Bacillus anthracis lethal factor Ab (qualitative, immunoassay) | MICRO |
| 106745-3 | Right ventricular End-diastolic volume fraction (mr) | HEMODYN.MOLEC |
| 106746-1 | Left ventricular End-diastolic volume (mr) | HEMODYN.MOLEC |
| 106747-9 | Right ventricular End-diastolic volume (mr) | HEMODYN.MOLEC |
| 106748-7 | Left ventricular End-diastolic volume index (mr) | HEMODYN.MOLEC |
| 106749-5 | Left ventricular End-systolic volume (mr) | HEMODYN.MOLEC |
| 10675-7 | Hepatitis B virus surface Ag (Tissue, qualitative, orcein stain) | MICRO |
| 106750-3 | Right ventricular End-systolic volume (mr) | HEMODYN.MOLEC |
| 106751-1 | Left ventricular End-systolic volume index (mr) | HEMODYN.MOLEC |
| 106752-9 | Right ventricular End-systolic volume index (mr) | HEMODYN.MOLEC |
| 106753-7 | Right ventricular End-systolic frame (mr) | HEMODYN.MOLEC |
| 106754-5 | Left ventricular End-systolic frame (mr) | HEMODYN.MOLEC |
| 106755-2 | Right ventricular End-diastolic frame (mr) | HEMODYN.MOLEC |
| 106756-0 | Left ventricular End-diastolic frame (mr) | HEMODYN.MOLEC |
| 106757-8 | Right ventricular Mass index (mr) | HEMODYN.MOLEC |
| 106758-6 | Left ventricular Mass index (mr) | HEMODYN.MOLEC |
| 106759-4 | Right ventricular Mass (mr) | HEMODYN.MOLEC |
| 10676-5 | Hepatitis C virus RNA (viral load) (probe with amplification) | MICRO |
| 106760-2 | Left ventricular Mass (mr) | HEMODYN.MOLEC |
| 106761-0 | Right ventricular Cardiac output (mr) | HEMODYN.MOLEC |
| 106762-8 | HIV pre exposure prophylaxis monitoring panel - Serum or Plasma | PANEL.MICRO |
| 106763-6 | Red reflex test (qualitative) | ADMIN.PATIENT |
| 106764-4 | Heart Shunt lesion type (us) | CARD.US |
| 106765-1 | Heart Shunt size (qualitative, us) | CARD.US |
| 106766-9 | Heart Shunt directionality (us) | CARD.US |
| 106767-7 | Ascending thoracic aorta Diameter (mr) | CARD.US |